Effect of Plasma Derived Exosomes on Cutaneous Wound Healing
Phase 1
Recruiting
- Conditions
- The participants are patients with intractable cutaneous ulcers (e.g. rheumatic disease, peripheral arterial disease, chronic venous insufficiency, decubitus or burns).
- Registration Number
- JPRN-UMIN000019885
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have ulcers with bone involvement. Patients who have ulcers with a history or suspected neoplasia. Patients who are in chemotherapy or radiation therapy on the skin ulcers. Patients with marked immunodeficiency (i.e., patients with severe liver failure, heart failure, hematologic failure or endocrine failure) Patients who have clinical signs of malnutrition or serum albumin <2 mg / dL. Patients who have severe infection. Patients who are pregnant or breastfeeding. Patients who are participating in another study. Patients who are judged inappropriate for this trial by their attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method lcer size (length, width, depth, mm) [Time Frame: 28 days]
- Secondary Outcome Measures
Name Time Method Pain of cutaneous wounds (Visual Analog Score for pain) [Time Frame: 28 days]